BALCHEM CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $56.0m $90.1m $78.6m $79.7m $84.6m $96.1m $105.4m $108.5m $128.5m $154.8m
Depreciation, Depletion and Amortization $46.2m $44.4m $44.7m $45.9m $51.3m $48.9m $51.8m $54.9m $48.0m $45.7m $48.0m
Amortization of Debt Issuance Costs $526k $474k $680k $282k $282k $282k $335k $287k $287k $288k
Amortization of Intangible Assets $29.8m $26.8m $25.0m $25.8m $27.8m $25.1m $27.3m $28.0m $19.2m $17.0m
Depreciation $15.9m $17.1m $19.0m $19.8m $23.0m $23.3m $24.0m $26.4m $28.2m $28.2m $48.0m
Depreciation Amortization Depletion $51.8m $54.9m $48.0m $45.7m $48.0m
Deferred Income Tax Expense (Benefit) ($6.9m) ($28.8m) ($5.4m) ($3.6m) ($4.6m) ($5.9m) ($8.4m) ($10.8m) ($6.8m) $6.3m ($5.8m)
Deferred Tax ($8.4m) ($10.8m) ($6.8m) $6.3m ($5.8m)
Share-based Payment Arrangement, Noncash Expense $7.0m $6.3m $6.4m $7.6m $8.3m $10.8m $13.2m $16.1m $16.7m $18.1m $19.7m
Gain (Loss) on Sale of Assets and Asset Impairment Charges ($53k) $366k ($7.0m) ($1.7m) $58k
Goodwill, Impairment Loss $1.2m
Restructuring Costs and Asset Impairment Charges $7.8m $521k
Asset Impairment Charge $1.7m $23k $7.0m
Nonoperating Income (Expense) ($7.9m) ($8.8m) ($6.1m) ($4.7m) ($2.3m) ($11.4m) ($21.9m) ($16.5m) ($10.3m)
Other Nonoperating Income (Expense) ($648k) ($1.2m) ($1.1m) ($116k) ($291k) $187k ($1.2m) $681k $72k ($77k)
Changes in operating assets and liabilities:
Change In Working Capital ($25.2m) $20.0m ($6.1m) ($7.5m) ($20.2m)
Increase (Decrease) in Accounts Receivable $15.7m $3.9m $7.8m ($11.6m) $3.6m $20.7m $3.6m ($7.0m) ($5.6m) $20.9m ($8.9m)
Change In Receivables ($3.6m) $7.0m $5.6m ($20.9m) ($8.9m)
Changes In Account Receivables ($3.6m) $7.0m $5.6m ($20.9m) ($8.9m)
Increase (Decrease) in Inventories ($4.7m) $319k $6.0m $11.4m ($13.9m) $21.0m $7.8m ($10.5m) $22.8m ($3.6m) ($27.5m)
Change In Inventory ($7.8m) $10.5m ($22.8m) $3.6m ($27.5m)
Change In Payables And Accrued Expense ($15.5m) $3.6m $9.1m $11.3m $24.6m
Net Cash Provided by (Used in) Operating Activities $107.6m
$110.6m +2.79%
$118.7m +7.30%
$124.5m +4.86%
$150.5m +20.92%
$160.5m +6.66%
$138.5m -13.69%
$183.8m +32.64%
$182.0m -0.96%
$216.6m +18.99%
$219.6m +1.41%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $23.0m $27.5m $19.2m $25.8m $32.1m $36.1m $49.1m ($37.9m) ($35.7m) ($43.5m) ($48.3m)
Capital Expenditure Reported ($49.9m) ($37.9m) ($35.7m) ($43.5m) ($48.3m)
Payments to Acquire Businesses, Net of Cash Acquired $110.6m $17.4m $17.4m $141.1m $0 $0 $365.8m $1.3m $24.2m $323k ($343k)
Net Other Investing Changes $206k $1.9m $359k $274k $14k
Net Cash Provided by (Used in) Investing Activities ($133.6m) ($42.7m) ($32.0m) ($156.2m) ($34.6m) ($35.3m) ($416.0m) ($34.8m) ($59.7m) ($43.9m) ($48.6m)
Cash flows from financing activities:
Repayments of Long-term Debt $35.0m $43.0m $219.5m ($143.2m)
Proceeds from Issuance of Long-term Debt $0 $105.0m
Issuance Of Debt $435.0m $18.0m $26.0m $88.0m $105.0m
Long Term Debt Issuance $435.0m $18.0m $26.0m $88.0m $105.0m
Long Term Debt Payments ($134.2m) ($149.2m) ($145.8m) ($114.2m) ($143.2m)
Net Issuance Payments Of Debt $300.8m ($131.2m) ($119.8m) ($26.2m) ($38.2m)
Net Long Term Debt Issuance $300.8m ($131.2m) ($119.8m) ($26.2m) ($38.2m)
Repayment Of Debt ($134.2m) ($149.2m) ($145.8m) ($114.2m) ($143.2m)
Payments for Repurchase of Common Stock $1.6m $1.9m $1.4m $21.3m $13.5m $35.2m $35.4m $4.5m $5.7m $107.6m
Common Stock Dividend Paid ($20.7m) ($22.9m) ($25.6m) ($28.3m) ($30.8m)
Common Stock Payments ($35.4m) ($4.5m) ($5.7m) ($107.6m) ($113.5m)
Net Common Stock Issuance ($35.4m) ($4.5m) ($5.7m) ($107.6m) ($113.5m)
Repurchase Of Capital Stock ($35.4m) ($4.5m) ($5.7m) ($107.6m) ($113.5m)
Dividends paid $10.7m $12.1m $13.4m $15.1m $16.7m $18.7m $20.7m $22.9m $25.6m $28.3m ($30.8m)
Dividends Payable, Current $12.1m $13.5m $15.2m $16.9m $18.9m $20.9m $23.1m $25.7m $28.5m $31.0m
Cash Dividends Paid ($20.7m) ($22.9m) ($25.6m) ($28.3m) ($30.8m)
Net Cash Provided by (Used in) Financing Activities ($68.6m)
($71.4m) -4.11%
$43.4m +160.72%
($101.2m) -333.18%
($102.2m) -1.00%
$246.7m +341.42%
($153.3m) -162.15%
($133.8m) +12.72%
($152.8m) -14.19%
($171.7m) -12.36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($716k) $2.5m ($1.4m) $11.4m $18.9m $18.7m ($36.7m) ($2.1m) ($14.9m) $25.1m $64.8m
Beginning Cash Position $103.2m $66.6m $64.4m $49.5m $65.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $65.7m $84.6m $103.2m $66.6m $64.4m $49.5m $74.6m $64.8m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($716k) $2.5m ($1.4m) ($217k) $4.2m ($4.4m) ($5.9m) $2.3m ($3.4m) $5.2m ($1.6m)
Effect Of Exchange Rate Changes ($5.9m) $2.3m ($3.4m) $5.2m ($1.6m)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $6.7m $7.0m $6.9m $5.7m $4.7m $4.5m $11.9m $25.9m $17.7m $10.6m
Income Taxes Paid, Net $33.0m $35.7m $42.6m $37.7m
Additional Financial Items
Derivative, Gain (Loss) on Derivative, Net ($1.7m) ($7.2m) $6.8m $6.5m ($2.5m)
Foreign Currency Transaction Gain (Loss), Unrealized $16k ($340k) $141k ($72k) ($384k) $914k ($733k) ($100k) ($680k)
Gain (Loss) on Disposition of Assets $3.2m $3.1m ($153k) $1.7m ($343k) $7.0m $1.7m ($58k)
General and Administrative Expense $27.5m $27.7m $27.7m $36.5m $43.8m $41.7m $55.7m $53.4m $67.6m $67.4m
Goodwill $439.8m $441.4m $448.0m $524.0m $529.5m $523.9m $769.5m $778.9m $780.0m $816.4m
Income Tax Expense (Benefit) $27.0m ($1.6m) $20.5m $16.8m $21.8m $29.1m $28.4m $28.7m $38.0m $44.2m
Investment Income, Interest $9k $12k
Operating Expenses $90.0m $91.8m $96.5m $108.8m $112.8m $115.7m $135.3m $142.9m $153.3m $161.3m
Payments of Financing Costs $1.4m $0 $0 $1.2m $0 $0
Proceeds from Stock Options Exercised $7.2m $9.7m $8.3m $4.8m $14.2m $6.9m $3.2m $5.2m $17.2m $9.3m
Cash Flow From Continuing Financing Activities $246.7m ($153.3m) ($133.8m) ($152.8m) ($171.7m)
Cash Flow From Continuing Investing Activities ($416.0m) ($34.8m) ($59.7m) ($43.9m) ($48.6m)
Change In Cash Supplemental As Reported ($36.7m) ($2.1m) ($14.9m) $25.1m
Change In Other Working Capital ($127k) $2.5m $1.8m ($205k) ($1.2m)
Change In Prepaid Assets $1.9m ($3.5m) $225k ($1.3m) $767k
Changes In Cash ($30.8m) ($4.4m) ($11.6m) $19.9m ($662k)
End Cash Position $66.6m $64.4m $49.5m $74.6m $64.8m
Financing Cash Flow $246.7m
($153.3m) -162.15%
($133.8m) +12.72%
($152.8m) -14.19%
($171.7m) -12.36%
Free Cash Flow $88.6m $145.9m $146.3m $173.1m $171.4m
Investing Cash Flow ($416.0m) ($34.8m) ($59.7m) ($43.9m) ($48.6m)
Net Business Purchase And Sale ($366.3m) ($1.5m) ($24.4m) ($676k) ($343k)
Net Foreign Currency Exchange Gain Loss $914k ($733k) ($100k) ($680k) ($436k)
Net Investment Purchase And Sale $0 $2.7m $0 $0 $0
Operating Gains Losses $1.3m $6.3m $1.6m ($738k) $798k
Other Non Cash Items ($11.3m) ($91k)
Proceeds From Stock Option Exercised $3.2m $5.2m $17.2m $9.3m $10.8m
Provisionand Write Offof Assets $401k $37k $299k ($97k) ($104k)
Purchase Of Business ($366.3m) ($1.5m) ($24.4m) ($676k) ($343k)
Sale Of Investment $0 $2.7m $0 $0 $0
Stock Based Compensation $13.2m $16.1m $16.7m $18.1m $19.7m